A method for detecting HPLC fingerprint of Lizhong Pills and fingerprint of Lizhong Pills and its application

Through HPLC technology and chemical pattern recognition analysis, the HPLC fingerprint map of Lizhong Wan was established, which solved the problem of insufficient determination of multiple chemical components of Lizhong Wan in the existing technology, achieved quality control and product consistency of Lizhong Wan, and ensured that Drug safety.

CN117805286BActive Publication Date: 2024-12-06LANZHOU FOOD & DRUG INSPECTION & TESTING INST
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410129777.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-30
Publication Date
2024-12-06
Estimated Expiration
2044-01-30

AI Technical Summary

Technical Problem

There is a lack of reports on the simultaneous determination of multiple chemical components in Lizhong Pills in the prior art, and it is difficult to fully control the quality of the preparation.

Method used

Using HPLC technology, the content of 10-gingerol, Codonopsis alkynyl glycoside, Atractylene lactone I, Atractylene lactone II, Glycyrrhizine, chlorogenic acid, glycyrrhizine and glycyrrhizine in Lizhong Pills was detected through high-performance liquid chromatography, and Combined with chemical pattern recognition analysis, the HPLC fingerprint of Li Zhongwan was established, and the detection wavelength, mobile phase, gradient elution conditions and extraction methods were determined to ensure the resolution and stability of the components.

Benefits of technology

The quality control of Li Zhong Pills is realized, the consistency and stability of the product is ensured, and accurate and reliable quality control methods are provided, which can quickly screen the different quality ingredients and ensure the safety of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117805286B_ABST
    Figure CN117805286B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of drug analysis technology, and in particular to a method for detecting HPLC fingerprints of Lizhong Pills and Lizhong Pills fingerprints and applications. The present invention respectively investigates different wavelengths, different extraction methods, different extraction volumes, different extraction solvents, different flow rates, different mobile phase systems, and finally determines that the sample extraction method is 25mL 70% methanol ultrasound (power 300W, frequency 40kHz) for 45min, with acetonitrile-water (containing 0.1% phosphoric acid) as mobile phase, gradient elution, detection wavelength of 215nm and 254nm, column temperature 30 DEG C, now each component chromatographic peak separation, peak shape is good, baseline is stable. Establish Lizhong Pills HPLC fingerprint, can better reflect the overall quality status of medicines, and then adopt chemical pattern analysis to screen out the difference between different batches of samples, the method is accurate and reliable, good repeatability, for the quality control of Lizhong Pills provides reference.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of drug analysis, and in particular to a method for detecting a HPLC fingerprint of a Lizhong Pill, a fingerprint of the Lizhong Pill and an application thereof. Background Art

[0002] Lizhong Pills come from Zhang Zhongjing's Treatise on Febrile and Miscellaneous Diseases. Lizhong means regulating the qi of the middle burner to connect yin and yang. The upper burner is yang, the lower burner is yin, and the middle burner is where yin and yang intersect. Lizhong Decoction warms the middle burner to connect the yin and yang of the upper and lower burners. This preparation is included in the 2020 edition of the Chinese Pharmacopoeia, which consists of four herbs: Codonopsis pilosula, Atractylodes macrocephala, Roasted Licorice, and Paojiang. [1] , in the prescription, Atractylodes macrocephala is the main ingredient, which greatly replenishes the soil of the middle palace. Dry ginger is pungent and hot, which can warm the qi of the middle palace and is the ministerial medicine. However, if it is too pungent and dry, it may damage the yin blood in the spleen, so Codonopsis pilosula, which is sweet, warm and moist, is used as an adjuvant, which combines hardness and softness. Roasted licorice is the guiding medicine. When used with Atractylodes macrocephala and dry ginger, it can transform the yang qi of the whole body; when used with Codonopsis pilosula, it can transform the yin blood of the whole body. In this way, the qi of the middle jiao is strong, the yin evil is eliminated, the middle jiao is greatly invigorated, and the body is naturally healthy and safe. It can be used clinically to treat spleen and stomach deficiency and cold, vomiting and diarrhea, chest fullness and abdominal pain, indigestion, etc.

[0003] As an efficient and accurate drug quality control method, HPLC fingerprint has been widely used in drug research and development and production. [2] By comparing the fingerprints of different batches of drugs, we can ensure the quality and efficacy of the drugs and provide patients with safe and reliable drugs. The current quality standard of this prescription only includes the determination of the content of licorice, and there are few reports on the simultaneous determination of multiple chemical components in Lizhong Pills.

[0004] In this study, the HPLC fingerprint of Lizhong Pills was established, and the contents of 10-gingerol, codonopsis ginsenoside, atractylodes lactone I, atractylodes lactone II, atractylodes lactone III, liquiritin, chlorogenic acid, liquiritigenin, and glycyrrhizic acid were determined. The methodological investigation was then combined with chemical pattern recognition analysis. [3] , to more comprehensively mine the information in the fingerprint data and quickly screen the components with quality differences, in order to provide a reference for the effective quality control of the preparation.

[0005] References

[0006] [1] Chinese Pharmacopoeia (2020 Edition) Volume 1 [S]. 2020: 1587.

[0007] [2] Ye Ting, Liang Wenyi, Liang Linjin, et al. Application of HPLC fingerprint in quality research of traditional Chinese medicine preparations [J]. World Science and Technology - Modernization of Traditional Chinese Medicine, 2017, 19(11): 1794-1800.

[0008] [3] Sun Lili, Wang Meng, Ren Xiaoliang. Application progress of chemical pattern recognition methods in traditional Chinese medicine quality control research [J]. Chinese Herbal Medicine, 2017, 48(20): 4339-4345. Summary of the invention

[0009] In view of the above technical problems, the primary purpose of the present invention is to provide a method for detecting Lizhong Pills HPLC, wherein the method is detected by a high performance liquid chromatograph, and the chromatographic conditions are as follows:

[0010] Column: Eclipse Plus C 18 , 250mm×4.6mm, 5μm;

[0011] Mobile phase: Phase A is acetonitrile or methanol, phase B is 0.1% phosphoric acid solution or water;

[0012] The gradient elution conditions were as follows:

[0013]

[0014] Flow rate: 0.8 mL min -1 ~1.0mL·min -1 ;

[0015] Column temperature: 30°C;

[0016] Detection wavelength: 215nm~276nm;

[0017] Injection volume: 10 μl.

[0018] Preferably, the mobile phase: phase A is acetonitrile, and phase B is 0.1% phosphoric acid solution.

[0019] Preferably, the flow rate is 0.8 mL min -1 .

[0020] Preferably, the detection wavelength is 215 nm and / or 254 nm.

[0021] The second object of the present invention is to provide a method for establishing a HPLC fingerprint of Lizhong Pills, the method comprising:

[0022] (1) Preparation of reference solution: Accurately weigh each reference substance, place it in a volumetric flask, dissolve it with methanol, and make up to volume to obtain a reference solution containing the standard component at a predetermined concentration. Store it at 4°C for later use;

[0023] (2) Preparation of test solution: accurately measure the sample, mix it with 10-50 ml of extraction solvent, extract, let it stand and cool, filter, and take the filtrate;

[0024] (3) HPLC detection

[0025] The test solution and the reference solution of (1) and (2) are detected by the method for detecting the fingerprint of Lizhong Pills according to claim 1 to obtain the fingerprint chromatogram of the test sample and the fingerprint chromatogram of the reference;

[0026] (4) Generate standard fingerprint

[0027] A standard fingerprint was generated based on the fingerprint chromatogram of the test sample, and the chromatographic peaks of the main components in Lizhong Pills with good separation were selected as characteristic peaks and determined as common peaks, and the common peaks were identified.

[0028] Preferably, the extraction solvent in step (2) is 30% methanol, 50% methanol, 70% methanol, methanol, water or 95% ethanol, with a volume of 10 to 50 ml.

[0029] Preferably, the extraction method in step (2) is heating reflux extraction or ultrasonic extraction.

[0030] The third object of the present invention is to provide a method for detecting the quality of Lizhong Pills, comprising: (1) obtaining a fingerprint of the Lizhong Pills product using the method for detecting the HPLC fingerprint of Lizhong Pills according to any one of claims 5 to 7; (2) comparing the fingerprint of the obtained Lizhong Pills product with the standard fingerprint. If the similarity is greater than 0.9, it indicates that the Lizhong Pills product is of qualified quality.

[0031] The fourth object of the present invention is to provide the application of the method for establishing the HPLC fingerprint of Lizhong Pills in detecting and identifying Lizhong Pills.

[0032] The fifth object of the present invention is to provide a fingerprint obtained by the method for establishing the HPLC fingerprint of Lizhong Pills.

[0033] The beneficial effects of the present invention are as follows: (1) The present invention investigates different wavelengths (215nm, 237nm, 254nm, 276nm), different extraction methods (heating reflux extraction, ultrasonic extraction), different extraction volumes (10ml, 25ml, 50ml), different extraction solvents (30% methanol, 50% methanol, 70% methanol, methanol, water, ethanol), different flow rates (0.8mL·min -1 、0.9mL·min -1 、1.0mL·min -1), different mobile phase systems (methanol-water, acetonitrile-0.1% phosphoric acid aqueous solution), and finally determined the sample extraction method as 25mL 70% methanol ultrasonic (power 300W, frequency 40kHz) treatment for 45min, with acetonitrile-water (containing 0.1% phosphoric acid) as the mobile phase, gradient elution, detection wavelengths of 215nm and 254nm, column temperature 30℃, at this time, the chromatographic peak separation and peak shape of each component were good, and the baseline was stable.

[0034] (2) The method for establishing the HPLC fingerprint of Lizhong Pills described in the present invention has good repeatability and stability within 24 hours, relatively stable quality, and good specificity and linear relationship.

[0035] Precision test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.63%, 2.62%, 2.98%, 2.97%, 1.62%, 2.16%, 2.46%, 2.84% and 2.70%, respectively, indicating that the instrument has good precision.

[0036] Repeatability test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.96%, 1.58%, 2.79%, 2.62%, 2.62%, 1.54%, 2.58%, 2.11% and 1.85%, respectively, indicating that this method has good repeatability.

[0037] Stability test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.62%, 2.39%, 2.50%, 1.95%, 2.65%, 1.57%, 2.77%, 1.89% and 0.98%, respectively, indicating that the solution had good stability within 24 hours.

[0038] Sample recovery test: The average recoveries of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, atractylodes lactone III, liquiritigenin, liquiritigenin and glycyrrhizic acid (n=6) were calculated to be 99.56%, 97.43%, 103.52%, 101.33%, 95.34%, 103.40%, 102.36%, 99.03% and 104.41%, respectively. The RSD values ​​were 1.38, 2.59, 2.12, 2.91, 2.95, 0.95, 1.42, 2.09 and 1.85, respectively, indicating that the method has good accuracy.

[0039] (3) The present invention establishes an HPLC fingerprint of Lizhong Pills, which is highly specific, accurate and reliable, and the pretreatment of the test solution is simple. According to the principle of "component measurability" of Q-Marker, it provides a reference basis for the comprehensive evaluation of the effective quality control of Lizhong Pills, and can be used to control the quality of Lizhong Pills. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 Chromatograms of the test solution under different mobile phase gradient elution methods Note: A is the chromatogram of the first mobile phase gradient elution method; B is the chromatogram of the second mobile phase gradient elution method; C is the chromatogram of the third mobile phase gradient elution method; D is the chromatogram of the fourth mobile phase gradient elution method; E is the chromatogram of the fifth mobile phase gradient elution method

[0041] Figure 2 Chromatograms of the test solution at different detection wavelengths

[0042] Figure 3 Chromatograms of test solution under different extraction methods

[0043] Figure 4 Chromatograms of the test solution at different extraction solvent volumes

[0044] Figure 5 Chromatograms of test solutions prepared with different extraction solvents

[0045] Figure 6 Chromatograms of test solution at different flow rates

[0046] Figure 721 Batch Lizhong Pills HPLC Overlay Spectrum (S1~S21) and Reference Spectrum (R)

[0047] Figure 8 Notes for HPLC chromatograms of sample and mixed reference solution: 1. Chlorogenic acid; 5. Liquorice glycoside; 6. Codonopsis pilosula glycoside; 8. Liquorice glycoside; 9. Glycyrrhizic acid; 17. Atractylodes lactone III; 23. Atractylodes lactone II; 27. Atractylodes lactone I; 28. 10-Gingerol.

[0048] Figure 921 Batch Sample CA Diagram

[0049] Figure 1021 PCA score graph of batch samples

[0050] Figure 1121 OPLS-DA score of samples

[0051] Fig.12 OPLS-DA model 200 permutation test graph

[0052] Fig.13 OPLS-DAVIP value chart of Lizhong Pills

[0053] Fig.14HPLC chromatogram of negative sample solution DETAILED DESCRIPTION

[0054] The present invention is further described in detail below in conjunction with test examples and specific implementation methods. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention.

[0055] Example 1: Optimization of the method for detecting the HPLC fingerprint of Lizhong Pills

[0056] 1 Materials

[0057] 1.1 Instrument

[0058] Waters e2695 liquid chromatograph (Waters, USA); XS105 DualRange 1 / 100000 balance (Mettler-Toledo, Switzerland); SBL-10DT ultrasonic constant temperature cleaning machine (Ningbo Xinzhi Biotechnology Co., Ltd.).

[0059] 1.2 Drugs and reagents

[0060] The reference substance chlorogenic acid (batch number: RDD-L00701908029, 98.00%) was from Chengdu Ruifensidedan Biotechnology Co., Ltd.; the reference substances 10-gingerol (batch number: 15456, ≥98.00%), codonopsis pilosula glycoside (batch number: 16550, ≥98.00%), atractylodes lactone I (batch number: 14232, ≥98.00%), atractylodes lactone II (batch number: 14498, ≥98.00%), atractylodes lactone III (batch number: 16202, ≥98.00%), liquiritin (batch number: 14310, 91.50%), liquiritigenin (batch number: 14207, ≥98.00%) and glycyrrhizic acid (batch number: 16277, 95.40%) were all purchased from Shanghai Shidande Biotechnology Co., Ltd. Lizhong Pills (Specification: Each pill weighs 9 g) 21 batches, numbered S1 to S21, see Table 1 for details. Acetonitrile was chromatographically pure; phosphoric acid and methanol were analytically pure; water was purified water; and other reagents were analytically pure.

[0061] Table 121 Information Source of Batch Lizhong Pills

[0062]

[0063] 2. Preparation of test solution

[0064] Weigh Lizhong pills and grind them into fine powder with an equal proportion of diatomaceous earth. Take about 2g of powder and weigh it accurately. Place it in a 150ml stoppered conical flask, use a pipette to draw 10-50mL of extraction solvent, weigh and record. After 45 minutes of extraction, cool and weigh again. Then use the extraction solvent to make up for the lost weight, shake well, and filter through a 0.45μm microporous filter membrane to obtain the product.

[0065] 3. Optimization of Chromatographic Conditions

[0066] 3.1 Selection of gradient elution method

[0067] Chromatographic conditions:

[0068] Table 2 Gradient elution ratio of the first mobile phase

[0069]

[0070] Table 3 Gradient elution ratio of the second mobile phase

[0071]

[0072] Table 4 Gradient elution ratio of the third mobile phase

[0073]

[0074] Table 5 Gradient elution ratio of the fourth mobile phase

[0075]

[0076]

[0077] Table 6 Gradient elution ratio of the fifth mobile phase

[0078]

[0079] The optimal wavelengths for different compounds are different. In order to ensure the response value of each compound, the test should be carried out as close to the optimal wavelength as possible. We selected two wavelengths for measurement, so the chromatographic peaks at the two wavelengths were added. Figure 1 A and B: The gradient elution ratio is consistent. Different mobile phase systems (methanol-water, acetonitrile-0.1% phosphoric acid aqueous solution) were investigated. Figure 1 In chromatogram A, the retention time is 14 to 25 min, the baseline fluctuates greatly, and the chromatographic peak separation is poor; Figure 1 B chromatographic behavior is better than Figure 1 A, therefore, the acetonitrile-0.1% phosphoric acid aqueous solution system was selected to optimize the elution gradient. Figure 1 In C, the chromatographic peak baseline is elevated at retention time 10-19 min, which may be mainly affected by excessive injection volume, column temperature, mobile phase ratio, etc. Figure 1 The separation of some chromatographic peaks in D is not enough. It is mainly affected by the flow rate of mobile phase, the gradient elution ratio of mobile phase, column efficiency or column type, etc. Figure 1 In E, the overall baseline is stable, the chromatographic information is rich, the separation of each index component is good, and the response is excellent.

[0080] 3.2 Selection of the optimal detection wavelength

[0081] Chromatographic conditions: Eclipse Plus C 18 Chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-10 min, 3%-14% A; 10-14 min, 14%-20% A; 14-18 min, 20%-25% A; 18-23 min, 25% A-35% A; 23-33 min, 35%-50% A; 33-43 min, 50%-58% A; 43-52 min, 58%-65% A; 52-55 min, 65%-75% A; 55-58 min, 75%-78% A; 58-59 min, 78%-3% A; 59-60 min, 3% A); flow rate: 0.8 mL min -1 ; Column temperature 35℃; Injection volume 10μL. The overall chromatographic behavior of the test solution at different wavelengths of 215nm, 237nm, 254nm, and 276nm was investigated.

[0082] like Figure 2 As shown in the figure, at a wavelength of 237 nm, the peak effect of each component is good, but the response values ​​of the index components, dangshen glycoside (optimal wavelength: 214 nm), glycyrrhizic acid (optimal wavelength: 250 nm) and atractylodes lactone I (optimal wavelength: 277 nm) are small at this wavelength. In order to make each component have a better peak effect as a whole in the chromatogram, two detection wavelengths were determined for determination after comprehensive consideration. That is, at a wavelength of 215 nm, dangshen glycoside, 10-gingerol, liquiritin, liquiritigenin, chlorogenic acid, atractylodes lactone III, and atractylodes lactone II were determined and analyzed; at a wavelength of 254 nm, glycyrrhizic acid and atractylodes lactone I were determined and analyzed.

[0083] 3.3 Selection of extraction method

[0084] Chromatographic conditions: Eclipse Plus C 18Chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-10 min, 3%-14% A; 10-14 min, 14%-20% A; 14-18 min, 20%-25% A; 18-23 min, 25% A-35% A; 23-33 min, 35%-50% A; 33-43 min, 50%-58% A; 43-52 min, 58%-65% A; 52-55 min, 65%-75% A; 55-58 min, 75%-78% A; 58-59 min, 78%-3% A; 59-60 min, 3% A); flow rate: 0.8 mL min -1 ; Detection wavelength: 215nm, 254nm; column temperature 35℃; injection volume 10μL.

[0085] Preparation of test solution:

[0086] (1) Hot reflux extraction Take an appropriate amount of Lizhong pills and an equal proportion of diatomaceous earth and grind them into fine powder. Take about 2g of the powder and weigh it accurately. Place it in a 150ml stoppered conical flask, use a 25.00ml pipette to draw 25mL of 70% methanol solution, weigh it and record it. After hot reflux extraction for 45min, cool it and weigh it again. Then make up the lost weight with 70% methanol, shake it well, and filter it through a 0.45μm microporous filter membrane to obtain it.

[0087] (2) Ultrasonic extraction Take an appropriate amount of Lizhong pills and an equal proportion of diatomaceous earth and grind them into fine powder. Take about 2g of powder and weigh it accurately. Place it in a 150ml stoppered conical flask, use a 25.00ml pipette to draw 25mL of 70% methanol solution, weigh and record. After ultrasonic extraction (power 300W, frequency 40kHz) for 45min, cool and weigh again. Then use 70% methanol to make up for the lost weight, shake well, and filter through a 0.45μm microporous filter membrane to obtain.

[0088] like Figure 3 As shown in the figure, the chromatographic behaviors of the test solutions prepared by the two extraction methods are very similar. Combined with the indicators such as chromatographic peak shape and separation, and taking into account the convenience of operation, ultrasonic extraction was finally selected as the better choice.

[0089] 3.4 Selection of extraction volume

[0090] Chromatographic conditions: Eclipse Plus C 18Chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-10 min, 3%-14% A; 10-14 min, 14%-20% A; 14-18 min, 20%-25% A; 18-23 min, 25% A-35% A; 23-33 min, 35%-50% A; 33-43 min, 50%-58% A; 43-52 min, 58%-65% A; 52-55 min, 65%-75% A; 55-58 min, 75%-78% A; 58-59 min, 78%-3% A; 59-60 min, 3% A); flow rate: 0.8 mL min -1 ; Detection wavelength: 215nm, 254nm; column temperature 35℃; injection volume 10μL.

[0091] Preparation of test solution: Grind an appropriate amount of Lizhong pills and diatomaceous earth in equal proportion into fine powder, accurately weigh 3 samples, each about 2g, and place them in 150ml stoppered conical bottles, accurately absorb 10ml, 25ml, and 50ml of 70% methanol, extract by ultrasound (power 300W, frequency 40kHz) for 45min, cool and weigh again. Then make up the lost weight with 70% methanol, shake well, and filter through a 0.45μm microporous filter membrane to obtain the solution.

[0092] like Figure 4 As shown in the figure, the chromatogram does not change significantly under different extraction solvent volumes. During the preparation of the test solution, it was found that when the extraction solvent volume was 10 ml, the test sample prepared had great resistance when filtered with a microporous filter membrane, making it inconvenient to filter. The extraction effects of 50 ml and 25 ml were relatively close. In order to save solvent usage and comprehensively consider environmental friendliness, the final extraction solvent volume was 25 ml.

[0093] 3.5 Selection of extraction solvent

[0094] Chromatographic conditions: Eclipse Plus C 18 Chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-10 min, 3%-14% A; 10-14 min, 14%-20% A; 14-18 min, 20%-25% A; 18-23 min, 25% A-35% A; 23-33 min, 35%-50% A; 33-43 min, 50%-58% A; 43-52 min, 58%-65% A; 52-55 min, 65%-75% A; 55-58 min, 75%-78% A; 58-59 min, 78%-3% A; 59-60 min, 3% A); flow rate: 0.8 mL min-1 ; Detection wavelength: 215nm, 254nm; column temperature 35℃; injection volume 10μL.

[0095] Preparation of test solution: Grind an appropriate amount of Lizhong pills and diatomaceous earth in equal proportion into fine powder, accurately weigh 6 samples, about 2g each, and place them in 150ml stoppered conical bottles, accurately absorb 25ml of 30% methanol, 50% methanol, 70% methanol, methanol, water, and 95% ethanol, respectively, extract by ultrasound (power 300W, frequency 40kHz) for 45min, cool and weigh again. Then make up the lost weight with 70% methanol, shake well, and filter through a 0.45μm microporous filter membrane to obtain the solution.

[0096] like Figure 5 As shown, 70% and 100% methanol have the best peak elution effect. After comparison, the difference between the two is small. Considering environmental friendliness and reducing the use of organic reagents, 70% methanol is determined as the extraction solvent.

[0097] 3.6 Flow rate selection

[0098] Chromatographic conditions: Eclipse Plus C 18 Chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-10 min, 3%-14% A; 10-14 min, 14%-20% A; 14-18 min, 20%-25% A; 18-23 min, 25% A-35% A; 23-33 min, 35%-50% A; 33-43 min n, 50%~58%A; 43~52min, 58%~65%A; 52~55min, 65%~75%A; 55~58min, 75%~78%A; 58~59min, 78%~3%A; 59~60min, 3%A); detection wavelength: 215nm, 254nm; column temperature 35℃; injection volume 10μL; flow rate of 0.8mL·min -1 、0.9mL·min -1 、1.0mL·min -1 The overall chromatographic behavior of the test solution.

[0099] Preparation of test solution: Grind an appropriate amount of Lizhong pills and an equal proportion of diatomaceous earth into fine powder, accurately weigh about 2g of the sample, place it in a 150ml stoppered conical flask, accurately add 25mL of 70% methanol solution, weigh and record. After ultrasonic extraction (power 300W, frequency 40kHz) for 45min, cool and weigh again. Then use 70% methanol to make up for the lost weight, shake well, and filter through a 0.45μm microporous filter membrane to obtain the solution.

[0100] like Figure 6 As shown, reducing the flow rate leads to better separation, good peak shape, high resolution and good stability. Therefore, the flow rate was determined to be 0.8 mL min -1 , used for sample analysis.

[0101] In summary, the present invention investigated different wavelengths (215nm, 237nm, 254nm, 276nm), different extraction methods (heating reflux extraction, ultrasonic extraction), different extraction volumes (10ml, 25ml, 50ml), different extraction solvents (30% methanol, 50% methanol, 70% methanol, methanol, water, ethanol), different flow rates (0.8mL·min -1 、0.9mL·min -1 、1.0mL·min -1 ), different mobile phase systems (methanol-water, acetonitrile-0.1% phosphoric acid aqueous solution), and finally determined the sample extraction method as 25mL70% methanol ultrasonic (power 300W, frequency 40kHz) treatment for 45min, with acetonitrile-water (containing 0.1% phosphoric acid) as the mobile phase, gradient elution, detection wavelengths of 215nm and 254nm, column temperature 30℃, at this time, the chromatographic peak separation and peak shape of each component were good, and the baseline was stable.

[0102] Example 2: Evaluation of the Optimal Method for Detecting Lizhong Pills HPLC Fingerprint

[0103] 1. Solution Preparation

[0104] 1.1 Preparation of reference solution

[0105] Accurately weigh 9.6530 mg, 9.0356 mg, 10.2510 mg, 8.8396 mg, 9.6432 mg, 8.2533 mg, 10.8878 mg, 10.1724 mg, and 9.4446 mg of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III, and glycyrrhizic acid reference substances, respectively, place them in a 10 ml volumetric flask, dissolve and dilute to the scale with methanol solution, and store at 4°C for later use.

[0106] 1.2 Preparation of test solution

[0107] Grind an appropriate amount of Lizhong pills and an equal proportion of diatomaceous earth into fine powder, take about 2g of powder and weigh it accurately. Place it in a 150ml stoppered conical flask, use a 25.00ml pipette to draw 25mL of 70% methanol solution, weigh and record. After ultrasonic extraction (power 300W, frequency 40kHz) for 45min, cool and weigh again. Then use 70% methanol to make up for the lost weight, shake well, and filter through a 0.45μm microporous filter membrane to obtain.

[0108] 1.3 Preparation of negative sample solution

[0109] According to the prescription process and proportion of this product, 5 negative samples were prepared respectively, namely, lacking Codonopsis pilosula, lacking Atractylodes macrocephala, lacking Codonopsis pilosula and Atractylodes macrocephala, lacking Licorice root and lacking Roasted ginger. They were prepared according to the method under "1.2".

[0110] 2. Optimal Chromatographic Conditions

[0111] Chromatographic column: Eclipse Plus C18 column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid solution (B); gradient elution according to Table 7; detection wavelength: 215 nm (10-gingerol, codonopsis pilosula, liquiritigenin, liquiritigenin, chlorogenic acid, atractylodes lactone III, atractylodes lactone II), 254 nm (glycyrrhizic acid, atractylodes lactone I); column temperature: 30 ° C; flow rate: 0.8 mL min -1 ; Injection volume: 10μl.

[0112] Table 7 Mobile phase gradient elution program

[0113]

[0114] 3. HPLC fingerprint establishment

[0115] 3.1 Precision test

[0116] Accurately weigh 2 g of the pill sample (S5), prepare the sample solution according to the method under "1", and inject the sample 6 times continuously under the chromatographic conditions under "2". Record the chromatogram, take Peak 5 (liquiritigenin) as the reference peak, and calculate the RSDs of the peak areas and relative retention times of the common peaks, which are less than 2.98% and 0.076%, respectively, indicating that the method has good precision.

[0117] 3.2 Repeatability test

[0118] Accurately weigh 2 g of the pill sample (S5), prepare 6 sample solutions in parallel according to the method under "1", inject the samples under the chromatographic conditions under "2", record the chromatogram, take Peak 5 (liquiritigenin) as the reference peak, calculate the RSDs of the peak areas and relative retention times of the common peaks, and they are less than 2.96% and 0.086%, respectively, indicating that the method has good repeatability.

[0119] 3.3 Stability test

[0120] Accurately weigh 2 g of the pill sample (S5), prepare the sample solution according to the method under "1", and measure the sample under the chromatographic conditions under "2" at room temperature at 0, 2, 4, 8, 12, and 24 h. Record the chromatogram, take Peak 5 (liquiritigenin) as the reference peak, and calculate the RSDs of the peak areas and relative retention times of the common peaks, which are less than 2.82% and 0.079%, respectively, indicating that the solution has good stability within 24 h.

[0121] 3.4 Fingerprint generation and similarity evaluation

[0122] Take 21 batches of Lizhong Pills samples (number: S1-S21) and record the chromatograms according to the methods of "1" and "2". Import the chromatogram data of the 21 batches of samples into the "Chinese Medicine Chromatographic Fingerprint Similarity Evaluation Software" (2012 Edition). Take the chromatogram of S5 sample as the reference spectrum, select the common peaks with strong absorption signal, good repeatability, obvious peak shape, high resolution and good stability for calibration, perform multi-point calibration and Mark peak matching on the relevant parameters of the 21 batches of samples, and generate the control characteristic spectrum of Lizhong Pills (R) and the HPLC fingerprint spectrum overlay of 21 batches of Lizhong Pills samples ( Figure 7 ), a total of 29 common peaks were confirmed, and compared with the reference substance ( Figure 8 ), 9 chromatographic peaks were identified, among which peak 1 was chlorogenic acid, peak 5 was liquiritigenin, peak 6 was codonopsis pilosula glycoside, peak 8 was liquiritigenin, peak 9 was glycyrrhizic acid, peak 17 was atractylodes lactone III, peak 23 was atractylodes lactone II, peak 27 was atractylodes lactone I, and peak 28 was 10-gingerol. The similarities between the characteristic spectra of samples S1 to S21 and the control were calculated to be 0.994, 0.973, 0.967, 0.969, 0.979, 0.972, 0.978, 0.975, 0.974, 0.973, 0.950, 0.935, 0.951, 0.923, 0.923, 0.909, 0.915, 0.962, 0.961, 0.958 and 0.959, all of which were > 0.90, with good similarity. It can be seen that the quality of each batch of Lizhong Pills samples is relatively stable.

[0123] 3.5 Cluster Analysis (CA)

[0124] The 29 common peak areas of 21 batches of Lizhong pills were imported into SIMCA 14.1 software. The peak area results were used as variables, and the distance between samples was calculated using the Ward method. The distance was used as a metric for cluster analysis. The results showed that ( Fig. 9 ), when the metric distance is 1e+007, 21 batches of Lizhong Pills samples can be divided into three categories: S2-S10 are the first category, S18-S21 are the second category, and the remaining batches are the third category. This shows that even when the fingerprint similarity is good, there are still certain differences in the quality of different batches of medicinal materials.

[0125] 3.6 Principal Component Analysis (PCA)

[0126] The 29 common peak areas of 21 batches of Lizhong pill samples were imported into SIMCA 14.1 software, and PCA analysis was performed with the peak area results as variables to obtain the PCA score graph of 21 batches of Lizhong pill samples ( Fig.10 ), it can be seen from the figure that the 21 batches of samples can be divided into three categories, among which S2~S10 are clustered into the first category, S18~S21 are clustered into the second category, and the remaining batches are clustered into the third category. This is consistent with the results of cluster analysis.

[0127] 3.7 Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA)

[0128] The 29 common peak areas in 21 batches of samples were imported into SIMCA 14.1 software, and the OPLS-DA model was automatically fitted. The results showed that the cumulative explanatory power parameter R 2 X=0.746、R 2 Y = 0.952, indicating that the model has a high degree of fit and high explanatory power. At the same time, the prediction ability parameter Q 2 =0.848, indicating that the constructed OPLS-DA has good prediction ability. Fig.11 The classification results show that the content differences between different batches of the same manufacturer are small, and the manufacturers can be clearly clustered into one category. The established model was tested 200 times, and the results are as follows Fig.12 As shown, R 2 and Q 2 The slope of the regression line is large, and all the R 2 and Q 2 The values ​​are all smaller than the original values ​​on the right, indicating that the constructed OPLS-DA model has no overfitting phenomenon and has good predictive ability, which can be used for further data analysis. Combined with the variable importance projection, the difference components that have a greater impact on sample classification are screened out ( Fig.13 ), there are 16 peaks with VIP>1.0, including peak 5, peak 21, peak 9, peak 27, peak 25, peak 15, peak 11, peak 14, peak 18, peak 13, peak 19, peak 8, peak 26, peak 17, peak 7, and peak 16, among which peak 5 is liquiritigenin, peak 9 is glycyrrhizic acid, peak 27 is atractylodes lactone I, peak 8 is liquiritigenin, and peak 17 is atractylodes lactone III, indicating that these 16 components are the main components affecting the classification differences of samples.

[0129] 4. Content Determination

[0130] 4.1 Specificity test

[0131] Take an appropriate amount of Lizhong Pills sample (S5) and prepare sample solution and reference solution ( Figure 8)、Negative sample solution( Fig.14 ), the sample was injected and measured under the chromatographic conditions of item "2", and it was found that the chromatographic peaks of each component had good separation, symmetrical peak shape, and matched one by one with the corresponding reference substances, indicating that the method had good specificity.

[0132] 4.2 Investigation of linear relationship

[0133] Take appropriate amount of each reference substance, prepare corresponding solutions of different mass concentrations according to the method under item "1", and inject and measure under the chromatographic conditions of item "2". Regression is performed with the mass concentration of the reference substance as the abscissa (X) and the peak area as the ordinate (Y). The results are shown in Table 8, which shows that the linear relationship of each component is good within its respective range.

[0134] Table 8 Linear relationships of various components

[0135]

[0136] 4.3 Precision test

[0137] The mixed reference solution under item "1" was sampled continuously for 6 times, and the RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.63%, 2.62%, 2.98%, 2.97%, 1.62%, 2.16%, 2.46%, 2.84% and 2.70%, respectively, indicating that the instrument has good precision.

[0138] 4.4 Repeatability test

[0139] Accurately weigh 2 g of the theorem pill sample (S5), prepare 6 sample solutions in parallel according to the method under "1", inject the samples under the chromatographic conditions under "2", record the chromatogram, and measure the peak area RSDs of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid, which are 2.96%, 1.58%, 2.79%, 2.62%, 2.62%, 1.54%, 2.58%, 2.11% and 1.85%, respectively, indicating that this method has good repeatability.

[0140] 4.5 Stability test

[0141] Accurately weigh 2 g of the pill sample (S5), prepare the sample solution according to the method under "1", and inject and measure the sample at room temperature at 0, 2, 4, 8, 12, and 24 h using the chromatographic conditions under "2". Record the chromatograms, and the RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritin, liquiritigenin, atractylodes lactone III, and glycyrrhizic acid were 2.62%, 2.39%, 2.50%, 1.95%, 2.65%, 1.57%, 2.77%, 1.89%, and 0.98%, respectively, indicating that the solution had good stability within 24 h.

[0142] 4.6 Sample recovery test

[0143] Take 6 portions of Lizhong Pills (S5) with known content from the same batch, each portion is about 1.00 g, and add each reference substance in the ratio of reference substance amount to sample content of 1:1. According to the operation under item "1", the sample addition recovery rate is determined and calculated under chromatographic condition "2". The average recoveries of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, atractylodes lactone III, liquiritin, liquiritigenin and glycyrrhizic acid (n=6) are 99.56%, 97.43%, 103.52%, 101.33%, 95.34%, 103.40%, 102.36%, 99.03% and 104.41%, respectively. The RSD values ​​are 1.38, 2.59, 2.12, 2.91, 2.95, 0.95, 1.42, 2.09 and 1.85, respectively, indicating that the method has good accuracy.

[0144] 4.7 Sample content determination

[0145] Take 21 (S2-S21) batches of pellet samples, prepare sample solution according to the method under item "1", inject and measure under the chromatographic conditions of item "2", calculate the content of each component, and the results are shown in Table 9.

[0146] Table 9.21 Results of determination of the contents of various components in Lizhong pills (mg·g -1 , n=3)

[0147]

[0148] The HPLC fingerprint of Lizhong Pills established in this study identified 29 common peaks. Compared with the reference substance, peaks 1, 5, 6, 8, 9, 17, 23, 27, and 28 were identified, which were chlorogenic acid, liquiritin, codonopsis pilosula, liquiritigenin, glycyrrhizic acid, atractylodes lactone III, atractylodes lactone II, atractylodes lactone I, and 10-gingerol, respectively. The similarity of the fingerprints of 21 batches of Lizhong Pills was above 0.900, indicating that the consistency between batches of Lizhong Pills was good, the chemical composition was basically the same, and the overall quality was stable. By combining chemical recognition pattern analysis, it was found that 21 batches of Lizhong Pills can be divided into three categories, which indicates that there are certain differences in the common components of different batches. The main peaks that affect the differences between batches are peak 5 (liquiritin), peak 21, peak 9 (glycyrrhizic acid), peak 27 (Atractylodes lactone I), peak 25, peak 15, peak 11, peak 14, peak 18, peak 13, peak 19, peak 8 (liquiritigenin), peak 26, peak 17 (Atractylodes lactone III), peak 7, and peak 16. This may be related to the content differences of medicinal materials from different origins and changes during transportation and storage. While constructing the fingerprint, the contents of 10-gingerol, codonopsis pilosula, chlorogenic acid, Atractylodes lactone I, Atractylodes lactone II, Atractylodes lactone III, liquiritin, liquiritigenin, and glycyrrhizic acid in Lizhong Pills were measured to be 0.14-0.41 mg·g, respectively. -1 , 0.02~0.08mg·g -1 , 0.06~0.64mg·g -1 , 0.08~0.15mg·g -1 , 0.03~0.06mg·g -1 , 0.13~0.58mg·g -1 , 0.51~1.63mg·g -1 , 0.07~0.28mg·g -1 , 1.91~2.76mg·g -1 The content of different batches from the same manufacturer varies little, while the content of ingredients from different manufacturers varies greatly. This may be related to factors such as the source, quality, processing methods and process control of raw materials during the production process.

[0149] In summary, (1) the present invention investigated different wavelengths (215nm, 237nm, 254nm, 276nm), different extraction methods (heating reflux extraction, ultrasonic extraction), different extraction volumes (10ml, 25ml, 50ml), different extraction solvents (30% methanol, 50% methanol, 70% methanol, methanol, water, ethanol), different flow rates (0.8mL·min -1 、0.9mL·min -1 、1.0mL·min -1), different mobile phase systems (methanol-water, acetonitrile-0.1% phosphoric acid aqueous solution), and finally determined the sample extraction method as 25mL 70% methanol ultrasonic (power 300W, frequency 40kHz) treatment for 45min, with acetonitrile-water (containing 0.1% phosphoric acid) as the mobile phase, gradient elution, detection wavelengths of 215nm and 254nm, column temperature 30℃, at this time, the chromatographic peak separation and peak shape of each component were good, and the baseline was stable.

[0150] (2) The method for establishing the HPLC fingerprint of Lizhong Pills described in the present invention has good repeatability and stability within 24 hours, relatively stable quality, and good specificity and linear relationship.

[0151] Precision test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.63%, 2.62%, 2.98%, 2.97%, 1.62%, 2.16%, 2.46%, 2.84% and 2.70%, respectively, indicating that the instrument has good precision.

[0152] Repeatability test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.96%, 1.58%, 2.79%, 2.62%, 2.62%, 1.54%, 2.58%, 2.11% and 1.85%, respectively, indicating that this method has good repeatability.

[0153] Stability test: The RSDs of the peak areas of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III and glycyrrhizic acid were 2.62%, 2.39%, 2.50%, 1.95%, 2.65%, 1.57%, 2.77%, 1.89% and 0.98%, respectively, indicating that the solution had good stability within 24 hours.

[0154] Sample recovery test: The average recoveries of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, atractylodes lactone III, liquiritigenin, liquiritigenin and glycyrrhizic acid (n=6) were calculated to be 99.56%, 97.43%, 103.52%, 101.33%, 95.34%, 103.40%, 102.36%, 99.03% and 104.41%, respectively. The RSD values ​​were 1.38, 2.59, 2.12, 2.91, 2.95, 0.95, 1.42, 2.09 and 1.85, respectively, indicating that the method has good accuracy.

[0155] (3) The present invention establishes an HPLC fingerprint of Lizhong Pills, which is highly specific, accurate and reliable, and the pretreatment of the test solution is simple. According to the principle of "component measurability" of Q-Marker, it provides a reference basis for the comprehensive evaluation of the effective quality control of Lizhong Pills, and can be used to control the quality of Lizhong Pills.

Claims

1. A HPLC method for detecting Lizhong Pills, characterized in that: The method described was detected by high performance liquid chromatography, and the chromatographic conditions were as follows: Column: Eclipse Plus C 18 , 250mm×4.6mm, 5μm; Mobile phase: Phase A is acetonitrile, phase B is 0.1% phosphoric acid solution; The gradient elution conditions were as follows: Column temperature: 30°C; Detection wavelength: 215nm~276nm; Injection volume: 10 μl; Preparation of test solution: weigh Lizhong pills, grind them into fine powder with an equal proportion of diatomaceous earth, take about 2g of powder and weigh accurately; put it in a 150ml stoppered conical flask, use a pipette to absorb 10-50mL of extraction solvent, weigh and record; after extraction for 45 minutes, cool and weigh again, then use extraction solvent to make up for the lost weight, shake well, and filter through a 0.45μm microporous membrane; the extraction solvent is 70% methanol; Preparation of reference solution: Accurately weigh 9.6530 mg, 9.0356 mg, 10.2510 mg, 8.8396 mg, 9.6432 mg, 8.2533 mg, 10.8878 mg, 10.1724 mg, and 9.4446 mg of 10-gingerol, codonopsis pilosula, chlorogenic acid, atractylodes lactone I, atractylodes lactone II, liquiritigenin, liquiritigenin, atractylodes lactone III, and glycyrrhizic acid reference substances, respectively, place them in a 10 ml volumetric flask, dissolve and dilute to the scale with methanol solution, and store at 4°C for later use.

2. The method according to claim 1, characterized in that The detection wavelength is 215nm and / or 254nm.

3. A method for establishing a HPLC fingerprint of Lizhong Pills, characterized in that: The method includes: (1) Preparation of reference solution: Accurately weigh each reference substance, place it in a volumetric flask, dissolve it with methanol, and make up to volume to obtain a reference solution containing the standard component at a predetermined concentration. Store it at 4°C for later use; (2) Preparation of the test solution: accurately measure the sample, mix it with 10-50 ml of extraction solvent, extract it, let it stand and cool, filter it, and take the filtrate to obtain the solution; the extraction solvent is 70% methanol; (3) HPLC detection The test solution and the reference solution of (1) and (2) above are detected by the HPLC method for detecting Lizhong Pills according to claim 1 to obtain the test sample fingerprint chromatogram and the reference sample fingerprint chromatogram; (4) Generate standard fingerprint A standard fingerprint was generated based on the fingerprint chromatogram of the test sample, and the chromatographic peaks of the main components in Lizhong Pills with good separation were selected as characteristic peaks and determined as common peaks, and the common peaks were identified.

4. The method for establishing the HPLC fingerprint of Lizhong Pills as claimed in claim 3, characterized in that: The extraction method of step (2) is heating reflux extraction or ultrasonic extraction.

5. A method for detecting the quality of Lizhong Pills, characterized in that: include: (1) Using the method for establishing the HPLC fingerprint of Lizhong Pills according to any one of claims 3 to 4, the fingerprint of the Lizhong Pills product is obtained; (2) The fingerprint of the obtained Lizhong Pills product is compared with the standard fingerprint. If the similarity is greater than 0.9, it indicates that the Lizhong Pills product is of qualified quality.

6. Application of the method for establishing the HPLC fingerprint of Lizhong Pills as described in any one of claims 3 to 4 in detecting and identifying Lizhong Pills.

Citation Information

Patent Citations

  • Building method for fingerprint of radix astragali seu hedysari pill with effect of reinforcing middle warmer

    CN106950324A

  • Zishen Yutai pill fingerprint constructing method and application thereof in quality detection

    CN110308213A

  • Method for establishing UPLC fingerprint spectrum of Xintong granules, fingerprint spectrum of Xintong granules and application of fingerprint spectrum

    CN113391002A

  • Radio transmission apparatus

    JP2005277942A